For both sexes, patients with NAFLD were older and had higher LAP, BMI, WC, SBP, DBP, FBG, platelet count, ALT, uric acid, TG, TC, and reduced TBIL, HDL-C levels than those observed in the subjects without NAFLD. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.